- July/August 2015
Thomas Helleday on an exciting new class of drug, MTH1 inhibitors.
- June 2015
Lesley Seymour and Jan Bogaerts on the future of RECIST.
- May 2015
Paul Workman on strategies for overcoming resistance to new drugs.
- April 2015
Highlights from the TAT Congress in Paris.
- March 2015
Christopher Wild on the exposome, a measure of environmental exposure.
- February 2015
Mathematicians are developing a blood flow model for metastasis.
- January 2015
René Bernards on discovering effective drug combinations.
- December 2014
Research on the high rate of burnout among young oncologists.
- November 2014
Carl June on the efficacy of CAR-T cells in treating leukaemia.
- October 2014
News from ESMO 2014 with Solange Peters and Alexander Eggermont.
- September 2014
Discussing how healthcare systems can meet the needs of cancer survivors.
EJC News Focus – January 2013
Predictions in Cancer for 2013
What will be the big news in your field in 2013? The availability of new drugs, perhaps? Long awaited phase III data which could set research on a new tack? Or the spiralling costs that will effectively block patients’ access to new treatment approaches? In this month’s EJC News Focus, Helen Saul asks Mary O’Brien, Richard Marais, Roger Stupp, Manuela Schmidinger and David Cameron what they expect to be the key issues in their field in the coming year.